Market Newsdesk

1.3 Billion Attacks Were Detected in Q3 of 2020, with 770 Million Representing Credential Stuffing and 49% Originating from Europe

Amazon Files Lawsuit Against Counterfeiters Using Social Media to Promote Sales

Bad Actors Attempted to Bypass Amazon’s Protections by Listing Generic Products while Purposefully Promoting Counterfeits to their Social Media Followers

SEATTLE–(BUSINESS WIRE)–
Amazon.com, Inc. (NASDAQ: AMZN), today announced a lawsuit against 13 individuals and businesses (collectively, the “defendants”) for advertising, promoting, and facilitating the sale of counterfeit luxury goods in Amazon’s store, in violation of Amazon’s policies and the law.

The lawsuit was filed in the United States District Court for the Western District of Washington and alleges the defendants operated in concert with each other to sell counterfeit products and engage in false advertising.

Among the 13 defendants, the lawsuit alleges that Kelly Fitzpatrick and Sabrina Kelly-Krejci conspired with sellers to evade Amazon’s anti-counterfeiting protections by promoting counterfeit products on Instagram and TikTok as well as their own websites. Fitzpatrick and Kelly-Krejci posted side-by-side photos of a generic, non-branded product and a luxury counterfeit product with the text, “Order this/Get this.” “Order this” referred to the generic product falsely advertised on Amazon, and “Get this” referred to the counterfeit luxury product. By posting only generic products on Amazon, Fitzpatrick and Kelly-Krejci – and the sellers they coordinated with – attempted to evade our anti-counterfeit protections while using social media to promote the true nature of these counterfeit products. Fitzpatrick and Kelly-Krejci also posted numerous videos describing the alleged high quality of the counterfeits they promoted.

”These defendants were brazen about promoting counterfeits on social media and undermined the work of legitimate influencers,” said Cristina Posa, Associate General Counsel and Director, Amazon Counterfeit Crimes Unit. “This case demonstrates the need for cross-industry collaboration in order to drive counterfeiters out of business. Amazon continues to invest tremendous resources to stop bad actors before they enter our store and social media sites must similarly vet, monitor, and take action on bad actors that are using their services to facilitate illegal behavior.”

Fitzpatrick was previously a member of the Amazon Influencer Program, but after Amazon detected her counterfeiting activities, she was removed from the program. She continued to advertise counterfeits using social media sites and directed followers to her own website. Amazon also detected and blocked Kelly-Krejci’s scheme and she similarly began to direct her followers to purchase counterfeits on her own website. The defendants also began directing their followers to other e-commerce websites:

“[N]ow as most of you know amazon [sic] has really cracked down on dupes … now they’re [sic] are barely any [dupes on Amazon],” said Fitzpatrick. “Our very trusted seller of the last year has moved to DH Gate … I know it’s a big change to switch from Amazon to DH Gate but this guarantees that the links do not get reported and shut down sometimes cancelling our orders.”

Amazon strictly prohibits counterfeit products in its stores, and in 2019 alone, invested more than $500 million to protect customers and brands from fraud, abuse, and counterfeit. Amazon’s proactive investments in preventing counterfeit include robust seller vetting, advanced machine-learning based technologies, and industry-leading brand protection tools like Project Zero, Brand Registry, and Transparency. As a result of Amazon’s efforts, 99.9% of all products viewed by customers on Amazon have not received a valid counterfeit complaint. In June 2020, Amazon launched its Counterfeit Crimes Unit, a global team with specialized experience in investigating and bringing legal action against bad actors.

Amazon has filed a series of lawsuits against counterfeiters, including a joint lawsuit with Italian luxury fashion house Valentino, cosmetics retailer KF Beauty, and seller of travel products for parents JL Childress.

You can see the court filing here:

• Case: 2:20-cv-01662, United States District Court for the Western District of Washington

Amazon has a number of tools to ensure customers receive authentic products and to protect brands’ intellectual property.

• Amazon Brand Registry, a free service that gives brand owners access to a powerful set of tools that help them deliver an accurate and trusted customer experience on Amazon while protecting a brand’s IP. More than 350,000 brands are enrolled. To enroll and learn more: https://brandservices.amazon.com/
• Transparency, a product serialization service that allows brands to uniquely identify each unit they produce through the application of unique codes on the product or its packaging. These codes allow Amazon to inspect and authenticate every unit enrolled in Transparency proactively, detecting and stopping counterfeits before they reach customers.
• Amazon’s Project Zero, which empowers brands to drive counterfeits to zero. Project Zero uses automated protections to proactively and continuously scan more than 5 billion attempted product listing updates daily to look for suspicious listings, provides a self-service tool for brands with an unprecedented ability to directly remove listings from Amazon’s stores, and leverages product serialization as an optional service. To join the more than 10,000 enrolled brands, learn more at: http://www.projectzero.com.
• Amazon’s Counterfeit Crime Unit (CCU), a global team that investigates and brings legal action against bad actors, protecting customers, brands, and Amazon’s selling partners. To learn more: https://press.aboutamazon.com/news-releases/news-release-details/amazon-establishes-counterfeit-crimes-unit-bring-counterfeiters

About Amazon

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201112005660/en/

Amazon.com, Inc.

Media Hotline

[email protected]

www.amazon.com/pr

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo

WaterMill Asset Management Releases Candid Q&As with Each of its Director Candidates for Election to Ziopharm Oncology’s Board

NEW YORK–(BUSINESS WIRE)–
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of the outstanding shares of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or the “Company”), today issued the below letter to shareholders that introduces the candid views of its three aligned, independent and qualified director candidates: Robert Postma, Jaime Vieser and Holger Weis.

As a reminder, WaterMill is seeking to reconstitute Ziopharm’s eight-member Board of Directors by removing four incumbents and installing our three-member slate. We encourage shareholders to consent to all of our proposals on the WHITE consent card. We urge shareholders to sign, date and return each WHITE consent card they receive.

Please visit www.FixZiopharm.com to download a copy of today’s letter and review relevant materials pertaining to our campaign.

***

November 12, 2020

Fellow Shareholders:

WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) recognizes that many of you have lost complete confidence in the incumbent Board of Directors (the “Board”) of Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) following a five-year period in which shareholders have seen the value of their equity plunge by more than 76%.¹ The Board’s demonstrated inability to reverse this value destruction has been compounded by what we believe has been its conscious decision to maintain an anti-shareholder culture that deprioritizes accountability, boardroom ethics, commercial vigor and corporate transparency. This is precisely why we are seeking to reconstitute the Company’s eight-member Board by removing four current directors (Scott Braunstein, J. Kevin Buchi, Elan Z. Ezickson and Scott Tarriff) and installing our three-member slate (Robert Postma, Jaime Vieser and Holger Weis).

It is important to reiterate at this time that WaterMill is not an activist investor and preferred to avoid any rancor with Ziopharm. But once it became clear to us that Chairman Scott Tarriff and Chief Executive Officer Laurence Cooper were not going to take the necessary steps to regain investor trust, we became convinced that pursuing targeted boardroom change on an expedited basis was in the best interest of all shareholders. We could not continue to sit on the sidelines as the incumbent Board flouts the basic tenets of sound corporate governance and presides over staggering share price declines.

Although Ziopharm’s leadership is apparently responding to our consent solicitation by spending an astounding seven-figure sum on external advisors tasked with helping the Company preserve the status quo, we encourage shareholders to focus on one “north star” question amidst all the noise: Will WaterMill’s director candidates help restore confidence and trust in the Board? The subsequent sections of this letter aim to help answer this key question by allowing shareholders to hear directly from each of our director candidates. The candid Q&As included in this letter should highlight the stark contrast between our slate, which embraces transparency, and the incumbents, who we are yet to see make themselves available in a similar manner.

LEARN ABOUT THE SORELY-NEEDED BUSINESS ACUMEN, COMMERCIAL INTENSITY AND OWNERSHIP PERSPECTIVES THAT WE BELIEVE MR. POSTMA WOULD BRING TO THE BOARD

Question #1: Why does your background as an investor qualify you to serve as a director?

Mr. Postma:For more than 40 years, I have found success investing in the private and public sector. I have overseen more than a dozen sizable investments in the biotechnology sector over the past decade. Prior to making each of those investments, I thoroughly analyzed each company’s capital position, financing options, governance profile and strategy for commercializing pre-clinical and clinical-stage assets. I have helped several early-stage biotechnology companies take their businesses to the next level by sharing strategic business guidance and effective capital allocation suggestions. If there is one thing I have learned over the past several years, it is that running the business is just as important as the actual science. I am skilled in business diligence in this sector and know that a strong corporate foundation can support the commercialization of scientific assets. Given the current composition of Ziopharm’s Board, which lacks both strategic prowess and strong ownership perspectives, I believe that my experience will be very additive.

Question #2: What steps would you take upon joining the Board?

Mr. Postma:The first thing that I would do is suggest to the Board that we have a candid discussion about performance, governance and shareholder engagement at Ziopharm over the past several years. Thereafter, I would suggest to my fellow directors that a Special Committee – which includes incumbent director representation – be formed to review Ziopharm’s ineffective corporate and financial strategy. Given my experience analyzing scores of biotechnology companies, I would be willing to join the Special Committee and help oversee its bottom-up assessment of the Company’s asset values, partnership opportunities, incentive structure, technology pipeline and talent pool. We can only turn around Ziopharm if we are willing to acknowledge and address the flaws that exist, including the Board’s track record of overseeing numerous deals in recent years that have been detrimental to the bottom line. This is why a Special Committee should review Ziopharm’s capital allocation policy and advise on the best path toward efficiently monetizing the Company’s prized assets. Shareholders have clearly lost confidence in the Board as it is currently constituted, but I believe Jaime, Holger and I can help regain their trust.

Question #3: What is the right long-term strategy for Ziopharm?

Mr. Postma:As a sizable shareholder with a long-term focus, I believe Ziopharm needs to focus on four strategic priorities in the months and years to come: developing a credible business plan, transparently communicating with shareholders, efficiently moving to monetize Ziopharm’s assets and prioritizing business development partnerships and non-dilutive sources of financing. I see a clear opportunity to turn Ziopharm into a successful biotechnology company with science that is well-positioned to receive approvals down the road – and I am dedicated to helping shareholders realize that vision.

Question #4: Should shareholders be concerned that WaterMill’s slate does not include an individual with prior experience as a public company director?

Mr. Postma:No. Many of the incumbent directors had public company experience prior to joining the Board, yet they have failed in their basic duties of ensuring proper oversight and accountability. This is why I urge investors to focus on our slate’s sizable 3.3% shareholdings and strong ownership perspectives as well as our respective skill sets. It is important to understand that WaterMill assembled a balanced slate, ranging from my biotechnology investing experience to Jaime’s capital allocation and financing expertise to Holger’s industry background and financial knowhow. This boardroom sorely needs shareholder representation and I believe that our slate’s intimate knowledge of the Company’s assets, appropriate sense of urgency and ownership perspectives will enable us to hit the ground running on day one.

LEARN ABOUT THE CAPITAL ALLOCATION EXPERTISE, FINANCE EXPERIENCE AND OWNERSHIP PERSPECTIVES THAT WE BELIEVE MR. VIESER WOULD BRING TO THE BOARD

Question #1: How can you help the Board develop an effective capital allocation framework?

Mr. Vieser:I would immediately seek to understand and question how, where and why the Company intends to allocate its financial and human resources over the next 18-24 months and help effectively communicate this to the shareholder base. In addition, I would remind the Board that dilutive share count increases, in the absence of greater transparency, are not a viable option for raising more capital based on the clear message shareholders sent at this past annual meeting. Unfortunately, the incumbent Board appears oblivious to these realities based on the fact that research and development costs have ballooned nearly 62% over the past 12-month period as deadlines were missed and shares tumbled. In addition to helping my fellow directors understand these considerations, I would help finally establish clear guardrails and tangible priorities for allocating the Company’s finite capital. One sensible step is reversing Ziopharm’s trend of growing its general and administrative costs and executive compensation each year.

Question #2: What role should a reconstituted Board play in guiding Ziopharm’s future financing initiatives?

Mr. Vieser:First and foremost, I believe a Board that has material ownership perspectives will likely stop trying to dilute shareholdersthrough poorly-conceived issuances. Insiders who are awarded equity – rather than purchasing shares on the open market – often have a seemingly cavalier attitude when it comes to share issuances. This appears to be the case at Ziopharm based on the massive proposed increase in authorized shares that was rejected at this past annual meeting. If I join the Board, I plan to work with the Board to help increase transparency and open doors to banks, lenders and prospective financial partners capable of providing the Company with less dilutive financing options.

Question #3: Given your years of experience investing in public companies, what is your assessment of Ziopharm’s corporate governance – and what needs to change?

Mr. Vieser:Ziopharm’s governance is plagued by an array of issues, ranging from concerning interconnectivity among the directors to excessive Board fees to a lack of boardroom diversity. I believe a reconstituted Board should reduce director compensation, tie management’s incentive pay to tangible metrics and commit to achieving enhanced diversity in the years to come. The Board needs to shift from its seemingly insular viewpoints to truly diverse perspectives.

Question #4: How does your skill set really differ from Mr. Postma’s skill set given he is also a fund manager?

Mr. Vieser:The main difference between the two of us is that I spent the first five years of my career as a banker helping finance public and private companies. Over the last 20 years, I have managed a multibillion dollar long/short portfolio of high yield, leveraged loan and distressed assets, participated in private equity deals and SPACs, and invested in a number of start-up companies in the biotechnology and technology worlds. I have been involved in dozens of restructurings over this time period as well. In each instance, the difference between success and failure has come down to a company’s ability to wisely manage and invest its finite amount of capital, which often means making difficult decisions. My background in both the banking and investing worlds will afford me a unique perspective into how Ziopharm should allocate its capital and manage its overall capital structure to help identify the least dilutive financing sources. I am also quite passionate about remaining abreast of sound corporate governance practices and studying how aligned executive compensation policies, boardroom diversity and social stewardship impact financial performance.

LEARN ABOUT THE INDUSTRY-SPECIFIC EXPERIENCE AND STRATEGIC PLANNING INSIGHTS THAT WE BELIEVE MR. WEIS WOULD BRING TO THE BOARD

Question #1: How can you help the Board improve its oversight of management, operations and strategic execution?

Mr. Weis:I have more than three decades of business and executive experience that includes focusing on corporate governance, finance and strategic business oversight. Based on my more than two decades working at life science companies, including leading a drug development program, I believe I am well positioned to help the reconstituted Board improve governance, strengthen internal financial controls, increase transparency and align compensation incentives with building shareholder value. In particular, I would volunteer to support a review of Ziopharm’s capital allocation plans and pipeline in order to uncover actionable insights for prioritizing the Company’s investments of money and time.All of this can help regain trust with the investment community.

Question #2: Based on your analysis of the immuno-oncology world, what additive perspectives would you bring to the Board?

Mr. Weis:A reconstituted Board needs to lean into the fact that this field is filled with intense competition and fast-paced developments. Winners and losers are separated by their ability to execute on strategic licensing opportunities and deal-making, which are important for scientific validation. I believe my business and drug development experience and analytical and strategic skills would add significant value to the Board as Ziopharm approaches a critical period for delivering value in each of its programs.

Question #3: Can you help Ziopharm address the material weakness in its internal controls over financial reporting, which was first reported in the Company’s 2019 10-K and in each subsequent 10-Q filing in 2020 (this was most recently disclosed on page 36 of the Company’s 10-Q filing)?

Mr. Weis:Yes.It is very concerning that a material weakness identified in 2019 remains uncorrected. A further concern is the lack of specific information the Company has provided about its remediation approach. As a former chief financial officer and executive at Ernst & Young, I have the skills to properly evaluate management’s remediation plans to ensure the timely resolution of this material weakness. The Board has a core responsibility to hold management accountable for maintaining a strong internal control structure.

Question #4: Should shareholders be concerned with your lack of public company director experience?

Mr. Weis:No. I spent years advising public companies and their leadership teams while at Ernst & Young. I have also been a company executive responsible for financial reporting and corporate governance. I am a Certified Public Accountant and understand Securities and Exchange Commission requirements. Most importantly, I have a keen senseof the meaning of fiduciary responsibilities.

THE CHOICE SHOULD BE CLEAR: OUR DIRECTOR CANDIDATES ARE ALIGNED, EXPERIENCED AND HAVE A PRO-SHAREHOLDER AGENDA

We hope that shareholders now have a clear sense of what our three-member slate would bring to the boardroom. In addition to possessing complementary expertise and a true vision for value creation, our director candidates are committed to transparency. That is why they are willing to communicate in an honest and open manner while, in our view, the current directors apparently want to hide behind external consultants.

Thank you for your robust engagement and support. Together we can fix Ziopharm for the benefit of all stakeholders, ranging from shareholders and employees to healthcare providers and patients.

Sincerely,

WaterMill Asset Management Corp.

***

We urge Ziopharm shareholders to consent to all five proposals on the WHITE consent card today by signing, dating and returning it in the postage-paid envelope provided.Please vote each and every WHITE consent card you receive since you may own multiple accounts. If you have already voted a Green revocation card from Ziopharm, a later-dated vote on the WHITE consent card will revoke that vote.

December 11, 2020 is our goal for the submission of written consents. Effectively, this means that you have until December 11, 2020 to consent to the proposals.

You may only consent by voting the WHITE consent card. Please throw away all Green revocation cards you receive.

^{____________________}

¹ Source: Bloomberg (data point reflects performance through October 15, 2020, which is the day before WaterMill filed its preliminary consent statement). 

View source version on businesswire.com: https://www.businesswire.com/news/home/20201112005657/en/

For Investors:

Saratoga Proxy Consulting LLC

John Ferguson / Joe Mills, 212-257-1311

[email protected] / [email protected]

For Media:

Profile

Greg Marose / Charlotte Kiaie, 347-343-2999

[email protected] / [email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Posted on November 12, 2020 9:03 am

Sonos Brings High-Definition Sound to Streaming Radio at Home with Sonos Radio HD

Sonos Brings High-Definition Sound to Streaming Radio at Home with Sonos Radio HD

Sonos Radio HD delivers an expanded catalogue of original radio stations from iconic artists and expert curators, kicking off with the world’s most beloved entertainer, Dolly Parton, all ad-free and in high-definition audio – the highest quality of any streaming radio service – only on Sonos.

SANTA BARBARA, Calif.–(BUSINESS WIRE)–
Sonos (Nasdaq: SONO), the leading sound experience company, debuts Sonos Radio HD, a new ad-free, high-definition streaming tier of its popular streaming radio service, Sonos Radio. Sonos Radio HD will feature even more exclusive content directly in the Sonos app, now in lossless, CD-quality audio – the highest quality sound of any radio streaming service. Sonos’ avid radio fans can now listen to Sonos Radio HD to explore exclusive genre stations, sounds for sleep and relaxation, and more in-depth artist content. Sonos Radio HD streams ad-free with skips and repeats, available on Sonos’ S2 app in the US and UK starting today with additional countries to follow. Sonos owners can subscribe on sonos.com for $7.99/£7.99 per month after a free, one month trial.

To start things off, Sonos collaborated with the world’s most beloved entertainer Dolly Parton to introduce Songteller Radio, an original station that will continually evolve with Dolly’s hits, favorite artists, and special commentary on songs and moments throughout her career.

Great music and entertainment have become the backdrop to daily life at home. For Sonos customers, alongside a 40% year-over-year increase in listening hours on Sonos globally, radio continues to represent 50% of all listening time on the platform. Complementary to the choice of more than 100 streaming services available on Sonos speakers, Sonos Radio HD builds on the early success of Sonos Radio, now the fourth most listened to service on Sonos since its April 2020 launch.

“Sonos Radio is a result of our unwavering commitment to great sound experiences – thoughtfully curated music in incredible sound from the moment our customers set-up,” said Patrick Spence, Sonos CEO. “Sonos Radio HD means even more choice and better sound for Sonos customers. As we continue to innovate to make listening to your favorite audio content at home easier and more enjoyable, Sonos Radio shows the potential of the new experiences we can bring from our platform of hardware, software, and services.”

Go Beyond the Playlist with Sonos Radio HD in Incredible Sound on Sonos

With Sonos Radio HD, all Sonos Radio original stations on both tiers stream in high-definition, lossless CD-quality audio (16-bit/44.1 kHz FLAC). Listening in high-definition audio delivers even more detail to the thousands of songs hand-selected for Sonos Radio, all curated and programmed for listening at home on Sonos.

Staying true to radio’s roots, Sonos Radio HD serves up a refreshing, yet reliable mix of fan favorites, deep cuts, generational throwbacks, and never-before-heard tracks and interviews in stations made by renowned artists, expert curators, and DJs.

“I had so much fun getting to share little stories and tidbits from the songs that have made up my life and career,” notes Parton. “My new station brings to life some of my favorite music and stories, similar to those that readers will explore in my first lyric book, Songteller, as well as my new Christmas album, A Holly Dolly Christmas. Sharing stories with fans is very special to me—and hopefully new listeners will enjoy them too!”

Exclusive Stations Available Starting Today on Sonos Radio HD

• Sonos Radio HD artist-curated stations go more in-depth on the obsessions, inspirations, and nostalgic tracks plus interviews heard nowhere else. Sonos Radio HD will kick-off with Dolly Parton’s Songteller Radio, hosted and curated by Dolly. Hear more music and stories in Dolly’s first show on Sonos Radio, Songteller Special, available on the station and for listeners everywhere on Mixcloud. New Sonos Radio HD artist-curated stations will drop regularly, including five new stations in early 2021.
• Deeper exploration into genres and music scenes with the help of curators and expert DJs including Nashville Now and Americana Ramble by Nashville-based music critic and author Ann Powers and iconic jazz performances on Unforgettable or Distant Kingdom for global retro R&B and soul.
• Soundtracks for homedebutas music has become the backdrop for cooking, working, and relaxing. Sonos Radio HD will highlight the physical and mental benefits of audio with original stations promoting mindfulness, productivity, and relaxation including The Inner Now, Chill Beats, and Mellow Morning.
• Perfectly tuned sleep soundswith six sleep stations for any preference – white noise, pink noise, brown noise, rain, rainforest and piano – mastered by Sonos’ sound experience team and artist soundboard and tuned specifically for Sonos speakers for the most natural, calming sounds for a better night sleep. Fall asleep to the steady sound of rain without loops or interruptions, and set an alarm for a peaceful start to the day with Mellow Morning.

Explore New Stations Free on Sonos Radio, Now Available in Five New Countries

In addition to more than 60,000 broadcast radio stations powered by long-time partners, Sonos Radio is the gift that keeps on giving with new original content coming to its current free tier just in time for the holidays.

• Ring in the holidays with two new holiday stations and a special radio show from Dolly Parton, Holly Dolly Christmas Special, following the release of her chart-topping holiday record. Dolly’s show will debut in November and December on Holidaze, one of two new holiday stations playing the best holiday hits and the other, Holiday Concerto, featuring instrumental renditions of holiday classics. Holly Dolly Christmas Special will also be available on Dolly’s Songteller Radio in HD and on the Sonos Mixcloud Archive for listeners everywhere.
• Take a deeper look into regional genres including British Beats and Bars, UK Session Sounds, French Connection, The Netherlands’ Radio à Gogo, German Zeitgeist, and Hip-Hop Stammtisch to explore the music and cultural flavors of favorite genres hand-picked by local curators.
• Sonos’ signature ad-free station, Sonos Sound System, explores the artist’s musical inspiration on a weekly Radio Hour with upcoming collaborations from Beverly Glenn-Copeland, Erykah Badu, A$AP Ferg, and Laurie Anderson. Listeners everywhere can tune in to past Radio Hours on the Sonos Sound System Archive at mixcloud.com/sonos.

Sonos Radio is available globally, pre-loaded in the Sonos app with original content streaming in 16 countries around the world, and beginning today, availability in Denmark, Norway, Switzerland, Austria, and Belgium.

About Sonos

Sonos (Nasdaq: SONO) is one of the world’s leading sound experience brands. As the inventor of multi-room wireless home audio, Sonos innovation helps the world listen better by giving people access to the content they love and allowing them to control it however and wherever they choose. Known for delivering an unparalleled sound experience, thoughtful design aesthetic, simplicity of use, and an open platform, Sonos makes the breadth of audio content available to anyone. Sonos is headquartered in Santa Barbara, California. Learn more at www.sonos.com.

About Sonos Radio

Sonos Radio is the premiere radio experience, only on Sonos. Built for and inspired by Sonos customers, Sonos Radio represents the broadest selection of radio available around the world, bringing together more than 60,000 broadcast radio stations from long-time partners along with dozens of exclusive original stations from Sonos. Available free to all customers globally, Sonos Radio is an ad-supported streaming radio service that comes pre-loaded in the Sonos App, bringing all streaming radio into one place from the moment customers set-up. Sonos original content is available in the United States, Canada, United Kingdom, Germany, France, Italy, Sweden, Ireland, Netherlands, Australia, New Zealand, Belgium, Austria, Switzerland, Norway, and Denmark.

Available first in the United States and United Kingdom, Sonos Radio HD offers an upgraded, ad-free Sonos Radio experience that delivers an expanded catalogue of exclusive original content in high-definition, lossless CD-quality audio (16-bit/44.1 kHz FLAC). Customers who upgrade to Sonos Radio HD will enjoy all original stations across both tiers in high-definition audio with skips, repeats, and with no ads, excluding global broadcast stations.

Rhapsody’s “Powered by Napster,” a complete music and audio platform service, is powering the catalog and licensing for Sonos’ original stations on Sonos Radio and Sonos Radio HD.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201112005386/en/

Media Contact

Tom Lodge

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Technology Entertainment Online Mobile Entertainment Events/Concerts Other Entertainment General Entertainment Internet Music

MEDIA:

Logo